Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 9 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed with results

Key Signals

4 with results100% success

Data Visualizations

Phase Distribution

7Total

P 1 (1)

P 2 (3)

P 3 (1)

P 4 (2)

Trial Status

Completed7

Unknown1

Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT04214483Withdrawn

A Pilot Study to Explore the Role of Gut Flora in Acne

NCT02270411Completed

Inflammatory Cells From Various Pathologies

NCT05108025Phase 2UnknownPrimary

DMT310-005 Topical in the Treatment of Acne Rosacea

NCT03064438Phase 2CompletedPrimary

Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea

NCT04555525Phase 4CompletedPrimary

A Pilot Study on the Use of Seysara for Rosacea

NCT03003104Phase 2CompletedPrimary

DMT210 Topical Gel in the Treatment of Acne Rosacea

NCT02147691Phase 4CompletedPrimary

Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study

NCT00580723Phase 1CompletedPrimary

Effects of PRK 124 Lotion in Acne Rosacea

NCT00041977Phase 3CompletedPrimary

Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea

Showing all 9 trials

Acne Rosacea